Dr. Mason Antone Schmutz, MD

Dr. Schmutz practices at Central Utah Eye Associates in Provo, Utah.

Dr. Schmutz's NPI, 1952664468, was assigned on June 19, 2012. Dr. Schmutz graduated from Boston University School of Medicine in 2012. Dr. Schmutz holds Utah license 10343475-1205.

Dr. Schmutz's primary practice is Central Utah Eye Associates, at 1735 N State St, Provo, UT 84604 in Utah County. The practice phone is (801) 374-1818.

Dr. Schmutz's primary practice is Central Utah Eye Associates in Provo, Utah. Dr. Schmutz is also affiliated with Sanpete Valley Hospital. Dmand AI also links Dr. Schmutz to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schmutz practices, 2 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Schmutz's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dmand AI has Dr. Schmutz's licenses on file in 3 states: Utah, California and Massachusetts.

CMS data shows 2,506 Medicare services from Dr. Schmutz across 14 procedure codes in 2024, for 738 Medicare patients. Medicare paid $210,260 for them.

CMS counts 738 Medicare patients who saw Dr. Schmutz in 2024. The largest group is 75 to 84, with 303 patients. 66% of them have high blood pressure, and 64% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schmutz's median patient age at 68, with 58% women.

In 2024, Dr. Schmutz wrote 4,574 Medicare Part D claims for 798 patients. 78% of them were for generic drugs. CMS names the drug for 4,435 of them, across 23 drugs with 11 or more claims each, at $264,738 in total drug cost. In 2023, CMS named 3,994 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Schmutz for performance year 2024, reported as part of a group. Dr. Schmutz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 296 procedures of cataract surgery by Dr. Schmutz, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Schmutz, published from 2012 to 2021. 2017 was the busiest year, with 3. The most frequent topics are Intraocular Pressure, Glaucoma and Latanoprost. Dr. Schmutz has published most often in J Glaucoma. Dr. Schmutz's most frequent co-authors are Sameh Mosaed, MD, Sarah Farukhi Ahmed, MD and Anand Bipin Bhatt, MD.

CMS Open Payments shows 74 general payments to Dr. Schmutz from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Alcon Laboratories Inc paid the most, $460.

Dr. Schmutz graduated from Boston University School of Medicine in 2012.